US Bancorp’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.3M | Sell |
138,620
-453
| -0.3% | -$85.2K | 0.03% | 281 |
|
|
2026
Q1 | $27.4M | Buy |
139,073
+9,521
| +7% | +$1.84M | 0.03% | 266 |
|
|
2025
Q4 | $23.8M | Buy |
129,552
+8,461
| +7% | +$1.48M | 0.03% | 298 |
|
|
2025
Q3 | $18.6M | Buy |
121,091
+7,533
| +7% | +$1.14M | 0.02% | 336 |
|
|
2025
Q2 | $15.9M | Sell |
113,558
-4,823
| -4% | -$676K | 0.02% | 354 |
|
|
2025
Q1 | $17.4M | Sell |
118,381
-1,236
| -1% | -$179K | 0.02% | 337 |
|
|
2024
Q4 | $15.7M | Buy |
119,617
+3,407
| +3% | +$477K | 0.02% | 357 |
|
|
2024
Q3 | $18.1M | Buy |
116,210
+7,483
| +7% | +$1.21M | 0.02% | 343 |
|
|
2024
Q2 | $17M | Buy |
108,727
+11,797
| +12% | +$1.78M | 0.02% | 337 |
|
|
2024
Q1 | $13.1M | Buy |
96,930
+3,615
| +4% | +$479K | 0.02% | 374 |
|
|
2023
Q4 | $12.6M | Buy |
93,315
+15,626
| +20% | +$2.03M | 0.02% | 377 |
|
|
2023
Q3 | $10.5M | Buy |
77,689
+7,162
| +10% | +$978K | 0.02% | 385 |
|
|
2023
Q2 | $10.1M | Sell |
70,527
-205
| -0.3% | -$30.2K | 0.02% | 405 |
|
|
2023
Q1 | $9.82M | Buy |
70,732
+14,353
| +25% | +$1.93M | 0.02% | 409 |
|
|
2022
Q4 | $7.65M | Sell |
56,379
-4,316
| -7% | -$541K | 0.01% | 460 |
|
|
2022
Q3 | $6.66M | Sell |
60,695
-3,340
| -5% | -$424K | 0.01% | 456 |
|
|
2022
Q2 | $8.46M | Buy |
64,035
+5,668
| +10% | +$744K | 0.02% | 407 |
|
|
2022
Q1 | $7.75M | Buy |
58,367
+7,935
| +16% | +$952K | 0.01% | 473 |
|
|
2021
Q4 | $5.88M | Sell |
50,432
-447
| -0.9% | -$52.6K | 0.01% | 545 |
|
|
2021
Q3 | $6.11M | Buy |
50,879
+13,722
| +37% | +$1.6M | 0.01% | 525 |
|
|
2021
Q2 | $4.45M | Buy |
37,157
+1,637
| +5% | +$180K | 0.01% | 596 |
|
|
2021
Q1 | $3.53M | Sell |
35,520
-2,882
| -8% | -$290K | 0.01% | 645 |
|
|
2020
Q4 | $3.84M | Buy |
38,402
+1,920
| +5% | +$203K | 0.01% | 595 |
|
|
2020
Q3 | $4M | Sell |
36,482
-6,434
| -15% | -$716K | 0.01% | 548 |
|
|
2020
Q2 | $4.54M | Sell |
42,916
-686
| -2% | -$70.8K | 0.01% | 506 |
|
|
2020
Q1 | $3.89M | Buy |
43,602
+215
| +0.5% | +$20.2K | 0.01% | 488 |
|
|
2019
Q4 | $4.33M | Sell |
43,387
-269
| -0.6% | -$25.3K | 0.01% | 552 |
|
|
2019
Q3 | $3.89M | Buy |
43,656
+15,911
| +57% | +$1.38M | 0.01% | 567 |
|
|
2019
Q2 | $2.29M | Buy |
27,745
+1,913
| +7% | +$150K | 0.01% | 730 |
|
|
2019
Q1 | $2.09M | Sell |
25,832
-7,183
| -22% | -$566K | 0.01% | 748 |
|
|
2018
Q4 | $2.51M | Buy |
33,015
+778
| +2% | +$60.8K | 0.01% | 655 |
|
|
2018
Q3 | $2.55M | Sell |
32,237
-8
| -0% | -$605 | 0.01% | 718 |
|
|
2018
Q2 | $2.26M | Sell |
32,245
-2,861
| -8% | -$206K | 0.01% | 756 |
|
|
2018
Q1 | $2.46M | Buy |
35,106
+2,825
| +9% | +$196K | 0.01% | 714 |
|
|
2017
Q4 | $2.24M | Buy |
32,281
+3,227
| +11% | +$218K | 0.01% | 753 |
|
|
2017
Q3 | $1.97M | Buy |
29,054
+1,914
| +7% | +$121K | 0.01% | 793 |
|
|
2017
Q2 | $1.85M | Sell |
27,140
-4,145
| -13% | -$271K | 0.01% | 796 |
|
|
2017
Q1 | $1.95M | Sell |
31,285
-18,645
| -37% | -$1.09M | 0.01% | 787 |
|
|
2016
Q4 | $2.73M | Sell |
49,930
-8,533
| -15% | -$485K | 0.01% | 634 |
|
|
2016
Q3 | $3.84M | Sell |
58,463
-12,101
| -17% | -$791K | 0.01% | 525 |
|
|
2016
Q2 | $4.26M | Buy |
70,564
+15,389
| +28% | +$894K | 0.02% | 478 |
|
|
2016
Q1 | $3.11M | Sell |
55,175
-8,209
| -13% | -$493K | 0.01% | 569 |
|
|
2015
Q4 | $4.3M | Buy |
63,384
+4,819
| +8% | +$316K | 0.02% | 477 |
|
|
2015
Q3 | $3.73M | Buy |
58,565
+8,978
| +18% | +$591K | 0.02% | 509 |
|
|
2015
Q2 | $3.16M | Buy |
49,587
+9,748
| +24% | +$667K | 0.01% | 586 |
|
|
2015
Q1 | $2.73M | Sell |
39,839
-18,672
| -32% | -$1.3M | 0.01% | 623 |
|
|
2014
Q4 | $4.12M | Sell |
58,511
-12,155
| -17% | -$870K | 0.02% | 485 |
|
|
2014
Q3 | $5.05M | Sell |
70,666
-19,367
| -22% | -$1.42M | 0.02% | 429 |
|
|
2014
Q2 | $6.69M | Sell |
90,033
-50,004
| -36% | -$3.61M | 0.03% | 390 |
|
|
2014
Q1 | $9.09M | Buy |
140,037
+22,506
| +19% | +$1.45M | 0.04% | 325 |
|
|
2013
Q4 | $6.98M | Buy |
117,531
+8,024
| +7% | +$436K | 0.03% | 356 |
|
|
2013
Q3 | $5.69M | Buy |
109,507
+10,050
| +10% | +$505K | 0.03% | 381 |
|
|
2013
Q2 | $4.71M | Buy |
+99,457
| New | +$5.06M | 0.02% | 401 |
|
Other funds holding AZN
EP
IA
US Bancorp's AZN Position: Q2 2026 in Review
US Bancorp reduced its AstraZeneca (AZN) stake by 0.33% in Q2 2026, selling an estimated $85.2K and leaving 138,620 shares worth $26.3M. The position accounts for 0.03% of the portfolio, ranked #281.
US Bancorp first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.4M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- US Bancorp held 138,620 shares of AstraZeneca worth $26.3M as of Q2 2026.
- US Bancorp sold 453 AstraZeneca shares in Q2 2026, an estimated $85.2K.
- AstraZeneca made up 0.03% of US Bancorp's portfolio in Q2 2026, its #281 holding.
- US Bancorp first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- US Bancorp's AstraZeneca position peaked at $27.4M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.